Company Filing History:
Years Active: 2025
Title: Tadaaki Ioroi: Innovator in Pharmaceutical Formulations
Introduction
Tadaaki Ioroi is a notable inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work with liposome compositions and immune checkpoint inhibitors. With a total of 2 patents to his name, Ioroi continues to push the boundaries of medical science.
Latest Patents
Ioroi's latest patents include a combined pharmaceutical formulation comprising a drug-containing liposome composition and an immune checkpoint inhibitor. This invention aims to provide a pharmaceutical formulation that combines a liposome composition, where liposomes encapsulate a drug, with an immune checkpoint inhibitor. The formulation includes a hydrophilic polymer-modified diacylphosphatidylethanolamine, dihydrosphingomyelin, and cholesterols, with a specific molar ratio of sulfate ions to the drug. The administration of this formulation can occur simultaneously or sequentially.
Another significant patent by Ioroi is a combined pharmaceutical formulation comprising a gemcitabine-containing liposome composition and an immune checkpoint inhibitor. This invention focuses on encapsulating gemcitabine in a dissolved state within liposomes. The formulation also allows for simultaneous or sequential administration of the liposome composition and the immune checkpoint inhibitor.
Career Highlights
Tadaaki Ioroi is currently associated with Fujifilm Corporation, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in developing advanced drug delivery systems that enhance the efficacy of treatments.
Collaborations
Ioroi collaborates with esteemed colleagues such as Takashi Komori and Takeshi Matsumoto. Their combined efforts contribute to the advancement of pharmaceutical technologies and innovations.
Conclusion
Tadaaki Ioroi is a pioneering inventor whose work in pharmaceutical formulations is making a significant impact in the medical field. His innovative patents reflect a commitment to improving drug delivery systems and patient outcomes.